Site Selection

Facility Planning

Workforce Development

Business+Place

AD Editorial Board

Bill Luttrell

Senior Locations Strategist, Werner Global Logistics, Werner Enterprises
Bradley Migdal

Senior Managing Director, Business Incentives Practice, Cushman & Wakefield, Inc.
Brian Corde

Managing Partner, Atlas Insight
Christine Bustamante

National Co-Leader, Global Location and Expansion Services, State and Local Tax, KPMG LLP
Dan Levine

Practice Leader, Location Strategies and Economic Development, Oxford Economics, Inc.
Dan White

Senior Economist, Moody's Analytics
Dean J. Uminski, CEcD

Partner, Crowe Horwath
Dennis Cuneo

Partner , Fisher & Phillips
Eric Stavriotis

Senior Vice President, Advisory & Transaction Services, CBRE, Inc.
Gregory Burkart

Managing Director and City Leader, Site Selection & Incentives Advisory , Duff & Phelps, LLC
Jamie Lominack

Corporate Real Estate Manager, Michelin North America
Josh Bays

Principal, Site Selection Group, LLC
Les Cranmer

Senior Managing Director, Savills Studley
Marc Beauchamp

President & CEO, The CAI Global Group
Margy Sweeney

Founder and CEO, Akrete, Inc.
Michael McDermott

Consulting Manager, Global Business Consulting, Cushman & Wakefield
Minah Hall

Managing Director, True Partners Consulting LLC
Scott Kupperman

Founder, Kupperman Location Solutions
Scott Redabaugh

Managing Director, JLL
Stephen Gray

CEO, Gray Construction
Thomas J. Stringer, Esq.

Managing Director & Practice Leader, Site Selection and Business Incentives Group, BDO USA
Tim Feemster

Managing Principal, Foremost Quality Logistics

CryoXtract Instruments Plans To Expansion Of Its Advanced Scientific Manufacturing Facility

Area Development News Desk

06/14/2012

MassDevelopment, the Commonwealth's development and finance agency focusing on stimulating economic growth, provided an $800,000 Emerging Technology Fund Working Capital Loan to CryoXtract Instruments, a Woburn, Mass-based firm that develops and manufactures automated lab solutions to protect critical frozen biological samples.

MassDevelopment said loan proceeds will serve as an incentive to help expedite CryoXtract's commercialization efforts and support the company's planned expansion, adding several engineering, marketing, manufacturing, and administration jobs over the next 18 months.

"CryoXtract, located at 2 Constitution Way in Woburn, combines two of the Commonwealth's most vibrant industries: the life sciences and advanced manufacturing," said MassDevelopment President and CEO Marty Jones. "Through the Emerging Technology Fund, MassDevelopment is pleased to support innovations and new jobs at these cutting-edge businesses."

CryoXtract's discoveries protects advancements in molecular medicine. CryoXtract's one-of-a-kind Frozen Sample Aliquotting technology offers the only means to repeatedly extract critical research samples without exposing them to damaging freeze-thaw cycles that degrade their integrity.

"We are seeing rapidly growing interest in our unique automated solutions. The availability of high-quality biosamples is one of the most critical challenges and limiting factors to contemporary research, biomarker discovery, and personalized medicine, said Jorge de Dios, CryoXtract's CEO.

"The research, biopharma, and biobanking communities understand that our technology's ability to protect sample quality can bolster the success of critical research studies. This loan from MassDevelopment is a very important way to propel our growth plans and expand our research and Development, marketing and manufacturing activities in 2012 and beyond," he added.